Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001263160 | SCV001441243 | uncertain significance | Spectraplakinopathy type I | 2020-09-30 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001573392 | SCV002343170 | likely benign | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541604 | SCV003758683 | likely benign | Inborn genetic diseases | 2021-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001573392 | SCV004127811 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | MACF1: BS1, BS2 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573392 | SCV001799206 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573392 | SCV001973775 | likely benign | not provided | no assertion criteria provided | clinical testing |